Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
life sciences
national top stories
san diego blog main
san diego top stories
texas blog main
texas top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
biotech
clinical trials
bristol-myers squibb
celgene
deals
fda
johnson & johnson
nonalcoholic steatohepatitis
pfizer
startups
abbvie
aducanumab
avexis
biogen
What
news
9
×
roundup
9
×
bio
drug
nash
fda
medical
approved
biogen
biogen’s
biotech
catch
companies
devices
disease
drugs
help
latest
let’s
new
road
week
according
adu
aducanumab
akcea
alzheimer’s
amyloid
angst
announced
approval
aren’t
august
bagged
beats
bids
billions
biobridge
biopharmaceutical
brammer
Language
unset
Current search:
roundup
×
news
×
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
TX Roundup: TMC’s BioBridge to the UK, New Execs at Fannin & TechFW
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
